The Independent Voice of
European Private Equity

Advanced Search

Keensight buys majority stake in 3P Biopharmaceutical

Samantha Birchall 23 July 2019

Pan-European growth buyout firm Keensight Capital is taking a majority stake in 3P Biopharmaceutical, the Spanish-based contract development and manufacturing organisation.

Next article »

« Previous article

Related Articles

Bridgepoint invests in French risk manager Forward Global

02/05/24

Bruin Capital extends sports focus with acquisition of tech firm PlayGreen

02/05/24

BGF exits engineering design company Hydrock

02/05/24

Afinum exits IT services firm FAST LTA

02/05/24

Inflexion reaps over 6x return from exit of automotive tech company

02/05/24

Family law lender Level raises £10m

02/05/24